Megan Crumbaker - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Megan Crumbaker

This paper was not found in any repository, but could be made available legally by the author.

2020 Megan Crumbaker

ORCID

, Sarennya Pathmanandavel, Andrew O. Yam

ORCID

, Andrew Nguyen, Bao Ho, Lyn Chan, Jesse A. Ende, Christopher Rofe, Kamonwan Kongrak, Edmond M. Kwan

ORCID

ORCID

, Shikha Sharma, Trevor J. Pugh, Arnavaz Danesh, Joanne Keane and 3 other authors

Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)

Upload

This paper is made freely available by the publisher.

Megan Crumbaker

ORCID

, Eva K. F. Chan

ORCID

, Tingting Gong, Niall Corcoran, Weerachai Jaratlerdsiri

ORCID

, Ruth J. Lyons, Anne-Maree Haynes, Anna A. Kulidjian, Anton M. F. Kalsbeek

ORCID

, Desiree C. Petersen, Phillip D. Stricker

ORCID

, Christina A. M. Jamieson, Peter I. Croucher, Christopher M. Hovens, Anthony M. Joshua

ORCID

and 1 other authors

The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2019 Megan Crumbaker

ORCID

, Jean Wong, Anthony M. Joshua, Allan D. Spigelman

Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary center

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Atul Bhatnagar, Matthew J. McKay

ORCID

, Megan Crumbaker

ORCID

, Ketan Ahire, Peter Karuso

ORCID

, Howard Gurney, Mark P. Molloy

ORCID

Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry

Upload

This paper was not found in any repository, but could be made available legally by the author.

2017 Megan Crumbaker

ORCID

, Howard Gurney

Dose considerations for anti-cancer drugs in metastatic prostate cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Megan Crumbaker

ORCID

, Alexander Guminski, Howard Gurney, Dhanusha Sabanathan, Shirley Wong, Nick Pavlakis

Real-world experience of the feasibility and tolerability of the 2/1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia

Upload

This paper is made freely available by the publisher.

Megan Crumbaker

ORCID

, Leila Khoja, Anthony Joshua

AR Signaling and the PI3K Pathway in Prostate Cancer

Download from doi.org

Missing publications? Search for publications with a matching author name.